Study reveals regional disparities in Brazilian childhood leukemia mortality
An international study involving LMU found regional differences in childhood lymphoid leukemia mortality across Brazil. Why do children…
Strategic collaboration funds interdisciplinary projects to improve cancer care
Rice University’s Synthesis X Center and Houston Methodist Neal Cancer Center have awarded $90,000 in seed grants as…
New oral regimen matches standard intravenous therapy for acute myeloid leukemia
The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia…
Scientists develop a superior diagnostic tool to spot hidden gene fusions in pediatric cancer
Researchers have introduced a novel diagnostic method that can more sensitively detect gene fusions in B-cell acute lymphoblastic…
OICR funds four Ontario teams to develop next-generation cancer therapies
Better cancer care depends on better treatment options. That’s why the Ontario Institute for Cancer Research (OICR) is…
Study finds increasing rates of therapy-related acute myeloid leukemia
Some therapies used to treat cancer may increase the risk of later developing cancers that affect the blood.…
Engineered Listeria boosts innate immunity against cancer
After nearly 40 years of research on how Listeria bacteria manipulate our cells and battle our immune system…
Researchers Raise Concerns about Faster Aging, Possible Early-Onset Dementia, for Children and Young Adult Cancer Survivors
Adolescent and young adult cancer survivors age faster than their peers who did not have cancer, according to…
RNA Splicing Errors Drive Leukemia
By: Staff Writer | January 02, 2026 | 7 min. read | Share Summary A new study from Sylvester Comprehensive…
Young donor age proves critical for survival after stem cell transplantation
The selection of suitable donors is crucial for the long-term recovery of patients after an allogeneic hematopoietic stem…
Researchers identify key differences between two subtypes of chronic lymphocytic leukemia
Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and molecular differences…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…